Splash Beverage Group Battles to Save NYSE Listing Following Major Financial Deficit
Fort Lauderdale, Wednesday, 6 May 2026.
Facing a severe $15.3 million financial deficit, Splash Beverage Group must submit a rescue plan by May 29, 2026, banking on a strategic CBD merger to prevent NYSE delisting.
Strategic Maneuvers: The Medterra CBD Merger
Management is anchoring its recovery strategy on a potential business combination with Medterra CBD, LLC [1][2]. Splash Beverage Group has already executed a letter of intent and delivered a draft Merger Agreement to Medterra, which is currently pending review [1]. This transaction is designed to repair the balance sheet and support the company’s NYSE listing [2]. However, the execution of this deal carries significant uncertainty [alert! ‘The company explicitly notes that entering into a definitive agreement is uncertain and contingent on multiple factors’] [1]. A successful close requires Splash to raise adequate capital to retire Medterra’s existing debt and secure necessary third-party consents [1].
Market Realities and the Road to Resilience
Despite these structural adjustments, market sentiment remains deeply cautious. As of early May 2026, SBEV’s market capitalization has dwindled to just $2.81 million, accompanied by a “Strong Sell” technical sentiment signal [2]. The company’s valuation currently offers limited support for investors, characterized by a non-meaningful negative price-to-earnings (P/E) ratio and the absence of a dividend yield [2]. This reflects ongoing liquidity constraints that have historically plagued the company, such as when Q2 2024 revenues dropped to $1.05 million specifically due to capital limitations [4].